<DOC>
	<DOCNO>NCT01208883</DOCNO>
	<brief_summary>Treatment adaptation biological anatomical change occur treatment increase chance cure minimize radiation-induced toxicity head neck cancer patient . This trial investigate feasibility use repetitive per-treatment [ 18F ] FDG-PET acquire treatment adaptive [ 18F ] FDG-PET-voxel intensity-based intensity-modulated radiotherapy ( IMRT ) volumetric-modulated arc therapy ( VMAT ) head neck cancer .</brief_summary>
	<brief_title>A Feasibility Study On Continuous Adaptive 18fFdg-Pet-Guided Radiotherapy For Head Neck Cancer</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma , Squamous Cell</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<criteria>Histologically confirm squamous cell carcinoma oral cavity , oropharynx , hypopharynx larynx . Primary unresectable tumor and/or patient refuse surgery . Stage T14 ; T34 N0 Tany N13 cancer glottis . Multidisciplinary decision curative radiotherapy radiochemotherapy . Karnofsky performance status ≥70 % . Age ≥ 18 year old . Informed consent obtain , sign date specific protocol procedure . Treatment combine brachytherapy . Prior irradiation head neck region . Distant metastasis . Second primary tumor control Pregnant lactate woman . Creatinine clearance ( CockcroftGault ) ≤ 60 mL/min treatment . Allergy CTcontrast agent . Mental condition render patient unable understand nature , scope , possible consequence study . Patient unlikely comply protocol , i.e . uncooperative attitude , inability return followup visit , unlikely complete study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Primary non-operated squamous cell carcinoma oral cavity , oropharynx , hypopharynx larynx .</keyword>
</DOC>